Also Recaps 60 Minutes “Rocky Mountain High”Segment that Aired October 21
SAN DIEGO, Oct. 22, 2012 /PRNewswire/ — Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that its portfolio company, Red Dice Holdings, received national media attention for its Dixie Elixirs & Edibles brand on the 60 Minutes “Rocky Mountain High” segment this past Sunday, October 21. Today, Dixie Elixirs and Edibles landed on the front-page of Newsweek in a story entitled, “The New Pot Barons.” 60 Minutes, the most successful television broadcast in U.S. history, draws an average of over 13 million viewers a week. Newsweek circulates internationally to over 10 million readers through its print and online subscriptions.
Medical Marijuana, Inc. portfolio company, Red Dice Holdings, is the parent company of the Dixie Elixirs & Edibles brand and is tremendously excited by this international media attention, which comes less than 20 days before the U.S. Presidential Elections as well as voting on state ballot initiatives on several key medical marijuana legalization measures. To read more about these measures please visit: http://tinyurl.com/9s9s86t
Steve Croft’s 60 Minutes segment presented an inside look at a day in the life of the top professional medical marijuana businesses in Colorado, including the leading business: Dixie Elixirs and Edibles. Mr. Croft walked through Dixie’s state of the art, 27,000 square foot laboratory in Denver and marveled at its medicated elixirs and pharmaceutical grade capsules. As stated in the segment, Dixie is one of the medical marijuana businesses that has helped bring in excess of over 20 million dollars in tax revenue for the state of Colorado. It is helping to boost employment in a depressed U.S. economy and perhaps most importantly, the company is creating health and wellness products that thousands of people have come to rely on. Mr. Croft discussed how Dixie and other medical marijuana businesses continue to thrive in spite of the federal government’s hesitancy to remove medical marijuana from its illegal status in the Federal Controlled Substances Act that still lists it as a Schedule 1 Drug. It’s important to note, however, that this is a situation that could change, as last week marked the most monumental hearing in U.S. history to reverse the 20-year ruling.
During the segment and on the 60 Minutes website follow-up called “Overtime” a number of key points were made including the following:
Dixie Elixirs and Edibles is the leading manufacturer of edibles supplying most of the 500 plus dispensaries in Colorado.
-There is a growing acceptance and tolerance for medical marijuana, 17 states have now legalized its medical use.
-The growth part of the industry is in infused products.
-Medical marijuana in Colorado has provided thousands of jobs and occupies once vacant retail spaces (over 1 million square feet of leased space to date).
-Colorado has the most developed medical marijuana industry in the country.
Here is one of Mr. Kroft’s excerpts:
There is a fascinating green rush going on in Colorado and the most colorful of them- a guy named Tripp Keber…Keber predicts a $9 billion a year business nationwide by the end of 2016…He’s hoping to franchise Dixie in four other states by the end of the year…He offers patients Dixie X, medicinal benefits (in CBD Cannabidiol) without the euphoric effects…So if I have a tennis elbow, I just put the salve on my elbow to relieve my pain…Yes, that’s right.”
Today, the cover story of Newsweek, “The New Pot Barons,” presents an equally detailed look at the business people involved in medical marijuana growth, many of whom are Ivy-League educated. The article refers to the medical marijuana movement as the “Facebook” of our time and offers insight into the powerful players at the top of the industry who lobby for its legalization.
One of these powerful players is Dixie’s Tripp Keber. He’s described in the article as a wealthy, business savvy leader with an eye for smart and profitable investments. He is quoted as seeing a “bright horizon” in the field, and is a founding member and current Board Director of the National Cannabis Industry Association.
To view the 60 Minutes “Rocky Mountain High Segment” visit: http://www.cbsnews.com/8301-18560_162-57536827/medical-marijuana-will-colorados-green-rush-last/?tag=currentVideoInfo;videoMetaInfo.
To view the 60 Minutes “Overtime” segment visit: http://www.cbsnews.com/8301-504803_162-57536817-10391709/marijuana-like-youve-never-seen-it-before/?tag=contentBody;listingLeadStories
To view the Newsweek October 22 Cover Story, “The New Pot Barons” visit: http://www.thedailybeast.com/newsweek.html.
To view the Newsweek Cover Story Photo Gallery visit: http://www.thedailybeast.com/newsweek/galleries/2012/10/21/inside-the-pot-industrial-complex-photos.html
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company’s website at:
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
Investor Relations Contact:
Stuart T. Smith